Proteon Therapeutics

Waltham, United States Founded: 2001 • Age: 25 yrs Listed
Developer of cell therapies and investigational drug formulations for cancer and rare diseases

About Proteon Therapeutics

Proteon Therapeutics is a publicly listed company based in Waltham (United States) founded in 2001. Developer of cell therapies and investigational drug formulations for cancer and rare diseases. Proteon Therapeutics has raised $126.54 million across 6 funding rounds from investors including Bessemer Venture Partners, RA Capital and Perceptive Advisors. The company has 17 employees. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.

Company details

Founded in 2001 and based in Waltham, United States, Proteon Therapeutics operates in the biotechnology sector. Cell therapies for non-muscle invasive bladder cancer and lymphatic malformations are developed, alongside investigational phospholipid substrate replacement therapies for patients requiring parenteral support. Novel approaches are applied by combining modern scientific advancements with established mechanisms to advance treatment options for cancer and rare diseases.

  • Headquarters Waltham, United States
  • Employees 17
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website proteontherapeutics.com
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $126.54M (USD)

    in 6 rounds

  • Latest Funding Round
    $22M (USD), Post-IPO

    Aug 2017

  • Investors
  • Employee Count
    17

Funding Insights of Proteon Therapeutics

Proteon Therapeutics has successfully raised a total of $126.54M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $22 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $126.54M
  • Total Rounds 6
  • Last Round Post-IPO β€” $22M
  • First Round $12M

    (Sep 2007)

  • Investors Count 14

All 6 funding rounds of Proteon Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2017$22MPost-IPO––
May 2014$45MSeries D–Abingworth
Feb 2014$4.34MSeries B––
–
Aug 2011$15.2MSeries B––
–
May 2009$50MSeries B––
Sep 2007$12MSeries A––
Valuation history

14 investors in total: 14 institutional.

Investors in Proteon Therapeutics

Proteon Therapeutics has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, RA Capital and Perceptive Advisors.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare ecosystem is supported through investment and innovation by Deerfield.
deerfield.comNew York, United States
Early stage venture capital firm investing in US
1973abingworth.comLondon, United Kingdom
Early-stage life sciences and tech focused VC firm funding companies in the US
intersouth.comDurham, United States
Health-tech companies are targeted for venture capital investments.
1999perceptivelife.comNew York, United States
US life sciences companies are invested in by Skyline Ventures.
skylineventures.comPalo Alto, United States
Capital is invested in life science innovations for healthcare transformation.
tvm-capital.comMunich, Germany
VC firm investing in the US
prismventure.comWestwood, United States
dpbioventures.com
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
1911bvp.comRedwood City, United States
Delivers investment management services with a focus on portfolio construction and risk assessment.
2016fairmountfunds.comPhiladelphia, United States
Premium access

Investor details for Proteon Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Proteon Therapeutics

34 people are tracked at Proteon Therapeutics (17 in leadership, 9 in board & advisors, 8 in team); the tracked headcount is 17.

NameRoleGroup
Melissa Patterson
Director - Clinical Finance & ContractingLeadership
Karen Lee Errigo, PHR
Associate Director Human ResourcesLeadership
Brian Desch
Director Clinical OperationsLeadership
Hannah F.
VP, ControllerLeadership
Patrick Fabbio
Chief Financial OfficerLeadership
Jennifer Steinle
Executive Assistant to Chief Executive OfficerLeadership
Jesse Shefferman
Co-Founder, Director & CEOLeadership
Jacqueline Zummo
Co-Founder, SVP & Chief Scientific Operations OfficerLeadership
Maurizio M.
Senior Director, Lead Principal ScientistLeadership
Lisa Schlesinger
VP New Product Development And Market AccessLeadership
Sam Greene, CPA
Associate Director, Assistant ControllerLeadership
Andrea DiFiglia
Associate Director, Clinical SciencesLeadership
McKenna Metcalf
Director Clinical OperationsLeadership
Eppie Brown
Vice President, Clinical OperationsLeadership
Bill Conkling
Chief Commercial Officer (cco)Leadership
Leo Viana Nicacio
Chief Medical OfficerLeadership
Khushboo Belani
Senior Director, Clinical Sciences And Regulatory AffairsLeadership
Richard Levy
DirectorBoard & advisors
Michael Solomon
DirectorBoard & advisors
Barry Flannelly
DirectorBoard & advisors

14 more people are available in the full profile.

Premium access

Complete people profiles for Proteon Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Proteon Therapeutics

4 dated milestones of Proteon Therapeutics across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Proteon Therapeutics is founded.
  2. Funding First funding round of $12.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $22.0M.

Web traffic of Proteon Therapeutics

Websites that share an audience with Proteon Therapeutics (proteontherapeutics.com).

Similar websites

Websites whose visitors overlap most with Proteon Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
momentapharma.com
100%
#11,284,544View details
proteonsoftware.com
84%
View details

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Proteon Therapeutics (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Proteon Therapeutics

Proteon Therapeutics was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Proteon Therapeutics is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Proteon Therapeutics is a funded company, having raised a total of $126.54M across 6 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Sep 2007.

Proteon Therapeutics has 17 employees.

Founded in 2001 and based in Waltham, United States, Proteon Therapeutics operates in the biotechnology sector. Cell therapies for non-muscle invasive bladder cancer and lymphatic malformations are developed, alongside investigational phospholipid substrate replacement therapies for patients requiring parenteral support. Novel approaches are applied by combining modern scientific advancements with established mechanisms to advance treatment options for cancer and rare diseases.

Proteon Therapeutics has 14 investors. Key investors include Bessemer Venture Partners, RA Capital, Perceptive Advisors, Abingworth, and Deerfield.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available